Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Validation of a Machine Learning Model Based on Clinical and MRI Features for Predicting Pathological Complete Response in Rectal Cancer Following Neoadjuvant Chemoradiotherapy

NCT07509632 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT07509632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07509632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Validation of a Machine Learning Model Based on Clinical and MRI Features for Predicting Pathological Complete Response in Rectal Cancer Following Neoadjuvant Chemoradiotherapy
Lead sponsor
Peking University People's Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
February 4, 2026
Completion date
May 10, 2026
Enrollment
320 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

machine learning, neoadjuvant chemoradiotherapy, pathological complete response, rectal cancers